Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury Lorenzo Di Sarno, Serena Ferretti, Lavinia Capossela, Antonio Gatto, Valeria Pansini, Luigi Manni, Antonio Chiaretti Pharmaceuticals, 2026 Background: Traumatic brain injury (TBI) and hypoxic-ischemic encephalopathy (HIE) cause significant pediatric morbidity through primary insults and secondary cascades like excitotoxicity, neuroinflammation, and impaired plasticity. Nerve growth factor (NGF) promotes neuroprotection, anti-inflammation, and repair, but delivery challenges persist. This review evaluates preclinical and clinical evidence on intranasal human recombinant NGF (hr-NGF) to enhance neurorepair in pediatric TBI and HIE patients. It aims to clarify the potential of intranasal hr-NGF as part of future multimodal approaches to enhance brain repair and improve functional recovery across the lifespan. Methods: A PRISMA-guided literature search (2000–2025) was conducted across Scopus, PubMed, and Cochrane CENTRAL using terms like “intranasal NGF”, “TBI”, “HIE”, and “pediatric”. Eligible studies involved pediatric brain injury patients receiving NGF, with outcomes via clinical scales, imaging, or EEG. Results: Preclinical models showed that intranasal NGF reduces lesion volume, inflammation, and deficits while boosting angiogenesis and cholinergic function. Clinically, one child with meningitis and five TBI cases exhibited improved consciousness, spasticity, motor scores, cognition, and brain imaging. Three HIE cases gained voluntary movements, expressivity, and perfusion. No adverse events occurred related to hr-NGF administration. Conclusions: Intranasal hr-NGF safely reactivates plasticity in pediatric brain injury, yielding motor, cognitive, and neurophysiological gains. Preliminary data support multimodal use, but randomized trials are needed to optimize protocols and confirm efficacy.
Elucidating the role of group A Streptococcus genomics and pharyngeal microbiota in acute paediatric pharyngitis Flavio De Maio, Roberto Rosato, Marilena La Sorda, Antonio Gatto, Giulia Santarelli, Lorenzo Di Sarno, Barbara Fiori, Brunella Posteraro, Antonio Chiaretti, Maurizio Sanguinetti Scientific Reports, 2025 The post pandemic period has witnessed a notable increase in invasive Streptococcus pyogenes (GAS) infections across several countries. This surge has been partly attributed to the emergence of more virulent strains, and factors like the non-pharmaceutical interventions or the immunity debt. Despite its dual role as both a commensal and pathogen, our understanding of GAS carriage and the dynamics influencing the transition to invasive disease remains limited. In particular, the role of the pharyngeal microbiota in modulating GAS colonization and infection warrants further investigation. We performed a comprehensive analysis of a pediatric cohort in the post pandemic period collecting clinical data alongside diagnostic evaluations by using pharyngeal swabs and Rapid Antigen Detection Tests (RADTs) to differentiate GAS-positive from GAS-negative cases. Comparative genomic analyses were performed on clinical isolates to identify the prevalence of specific clones or virulence determinants. Additionally, the pharyngeal microbiota was characterized using 16 S rRNA targeted sequencing to assess differences in microbial community composition between the two groups. The overall composition of the pharyngeal microbiota appeared comparable between GAS-positive and GAS-negative children. Alpha diversity metrics (Observed Species, Shannon diversity and Pielou's Evenness) were not significantly different (p = 0.820, p = 0.280 and p = 0.240, respectively), while Bray-Curtis defined two distinct groups (PERMANOVA, p = 0.01, R² = 0.523). The relative abundance of S. pyogenes within the Streptococcus genus emerged as a key differentiator. Genomic analysis revealed a mosaic representation of GAS clones, with the emm12.0 that was the most represented type, suggesting genomic characteristics did not directly correlate with the upsurge of respiratory GAS infections in our cohort. Our study underscores the complexity of GAS pathogenesis, highlighting that the transition from colonization to infection (acute pharyngitis) remains largely elusive and pharyngeal microbiota may contribute to a multifaceted interplay between host immunity and S. pyogenes.
Factors Associated with More Severe Disease in Infants and Children with Pertussis in the Post-Pandemic Era: A Single-Center Retrospective Study Antonio Gatto, Danilo Buonsenso, Eleonora Rulli, Mariya Prokopchuk, Giuseppe Zampino, Maurizio Sanguinetti, Michela Sali, Marilena La Sorda Pathogens, 2025 Pertussis remains a potentially severe respiratory illness in pediatric populations, especially in vulnerable groups. A severe outbreak has been reported in the post pandemic era, but it is uncertain if risk factors for severe disease may have changed compared with pre-pandemic years. We conducted a retrospective analysis of children diagnosed with Bordetella pertussis infection at a single tertiary pediatric center, from January 2023 to May 2024 Clinical and demographic variables were compared between outpatients and hospitalized patients to identify factors associated with disease severity. A total of 71 patients were included. Younger age (p < 0.001), lower body weight, (p = 0.0005) and lack of vaccination (p < 0.00001) were significantly associated with hospitalization. No significant differences were found regarding clinical symptoms, oxygen saturation, fever, or viral co-infection. Conclusion: Unvaccinated status, younger age, and lower weight appear to be key risk factors for hospitalization in pediatric pertussis, underlining the protective role of vaccination and the vulnerability of younger infants. These findings support targeted vaccination efforts and early risk stratification to prevent severe disease in vulnerable infants.
Acute Peritoneal Dialysis in Critical Preterm Infants: A Case Series and Review of the Literature Francesca Riitano, Serena Ferretti, Simonetta Costa, Eloisa Tiberi, Antonio Gatto, Giovanni Vento Children, 2025 Background: Acute kidney injury (AKI) in critically ill neonates is usually of pre-renal origin and, often, pharmacological treatment is not sufficient for resolution, requiring kidney replacement therapy (KRT). Due to the small body size and the unavailability of adequate devices for these patients, peritoneal dialysis (PD) appears to be the most easily achievable procedure. However, guidelines for PD management are lacking in this population. Objective: We aimed to report a single-center experience with preterm infants who underwent PD, describing the technical issues and the outcomes, and to review the existing literature. Methods: This retrospective study included preterm infants undergoing PD because of AKI unresponsive to pharmacological treatment. Data were compared to those available in the current literature. Results: Neonatal outcomes of twelve preterm infants were reported. PD was started before the onset of anuria in two oliguric patients, while it was started within 60 h of anuria in four patients, and between 72 and 144 h of anuria in the remaining six patients. One oliguric patient and one who started PD after 60 h of anuria had a complete recovery of kidney function with normalization of diuresis and renal function parameters. The other infants did not achieve complete resolution of AKI. The mortality rate was 91.7%, and even one of the two infants who had recovered kidney function later died due to an infectious complication. Conclusions: Our experience with a limited sample size did not allow us to obtain definitive conclusions. Our data and the current literature suggested that the prognosis is still negative, with a high mortality rate. Further research is needed to develop guidelines to optimize the management of preterm infants with AKI.
Acute Poisoning in Children Presenting to the Pediatric Emergency Department: An Epidemiologic Study and the Impact of the SARS-CoV-2 Pandemic Lorenzo Di Sarno, Valeria Pansini, Anya Caroselli, Paolo Maurizio Soave, Antonio Gatto, Serena Ferretti, Lavinia Capossela, Antonio Chiaretti Medicina Lithuania, 2025 Background and Objectives: Acute poisoning is a frequent cause of pediatric emergency department visits and represents a significant public health issue, with children particularly vulnerable due to developmental and behavioral factors. This study aimed to characterize the clinical and demographic profiles of pediatric patients presenting with acute intoxication over a ten-year period (2014–2023) and to assess the impact of the SARS-CoV-2 pandemic on patterns of pediatric poisoning. Materials and Methods: A retrospective cohort study was conducted at the Fondazione Policlinico A. Gemelli in Rome, including all patients under 18 years presenting with acute intoxication between September 2014 and June 2023. Data were extracted from electronic medical records and categorized by age group (0–5, 6–11, and 12–18 years) and by three pandemic-related periods: Pre-COVID-19 (to March 2020), COVID-19 (March 2020–June 2021), and Post-COVID-19 (June 2021 onwards). Statistical analyses included chi-squared tests and Cramér’s V for effect size. Results: Of 794 PED admissions for acute intoxication, 64.5% involved children aged 0–5 years, and 24.9% involved adolescents. Most events occurred at home (63.2%) and were accidental (76.4%), with voluntary intoxications exclusively among adolescents. Drug ingestion was the leading cause (39.3%), followed by solvents (17.8%) and alcohol (7.8%), with alcohol-related cases rising markedly post-pandemic. Statistically significant associations were found between the pandemic period and both age group and intentionality of poisoning (p < 0.00001), but not gender. Voluntary and recreational intoxications increased during and after the pandemic, particularly among adolescents. Conclusions: Pediatric acute poisoning displays a bimodal age distribution, with accidental exposures predominant in young children, and intentional cases predominant in adolescents. The COVID-19 pandemic was associated with an increase in adolescent voluntary and recreational intoxications. These findings underscore the need for targeted prevention strategies addressing both household safety for young children and mental health and substance use interventions for adolescents.
Nerve Growth Factor in Pediatric Brain Injury: From Bench to Bedside Lorenzo Di Sarno, Serena Ferretti, Lavinia Capossela, Antonio Gatto, Valeria Pansini, Anya Caroselli, Luigi Manni, Marzia Soligo, Antonio Chiaretti Pharmaceuticals, 2025 Background: Traumatic brain injury (TBI) and hypoxic–ischemic encephalopathy (HIE) are major causes of long-term neurological disability in children, with limited options for effective neuronal recovery. Recent research has highlighted the therapeutic potential of nerve growth factor (NGF) in promoting neural repair through mechanisms such as neuroprotection, neurogenesis, and the modulation of neuroinflammation. This review evaluates the current evidence on NGF as a treatment strategy for pediatric brain injury, emphasizing its mechanisms of action and translational clinical applications. Methods: A comprehensive review was conducted using the PubMed, Scopus, and Cochrane CENTRAL databases to identify studies published between 1 January 1978 and 1 March 2025, investigating NGF in the context of brain injury. The inclusion criteria comprised studies assessing neurological outcomes through clinical scales, biochemical markers, neuroimaging, or electrophysiological examinations. Results: Seventeen studies met the inclusion criteria, encompassing both preclinical and clinical research. Preclinical models consistently demonstrated that NGF administration reduces neuroinflammation, enhances neurogenesis, and supports neuronal survival following TBI and HIE. Clinical studies, including case reports of pediatric patients treated with intranasal NGF, reported improvements in motor and cognitive function, neuroimaging findings, and electrophysiological parameters, with no significant adverse effects observed. Conclusions: NGF demonstrates significant promise as a neuroprotective and neuroregenerative agent in pediatric brain injury, with both experimental and early clinical evidence supporting its safety and efficacy. Large-scale controlled clinical trials are warranted to validate these preliminary findings and to determine the optimal dosage regimens and administration schedules for NGF in the treatment of TBI and HIE.
X-Ray Utilization Patterns in Pediatric Musculoskeletal Trauma: Assessing Potential Overprescription Antonio Gatto, Lavinia Capossela, Serena Ferretti, Marcello Covino, Lorenzo Di Sarno, Valeria Pansini, Antonio Chiaretti Iranian Journal of Pediatrics, 2025 Background: Traumatic injuries are among the leading causes of visits to the pediatric emergency department (PED). Objectives: This study aims to evaluate the pediatric approach to musculoskeletal trauma in children to determine whether the routine use of X-rays can be reduced by encouraging the use of ultrasound. Methods: This retrospective observational study included children aged 0 - 18 years admitted to the PED of the Policlinico A. Gemelli with a diagnosis of musculoskeletal trauma from January 2017 to December 2021. Patients were divided into two groups based on the presence of fractures identified through radiological examinations: "Fracture Yes" and "Fracture No." Data on X-rays performed were categorized according to the site of trauma. Results: A total of 5,972 children were enrolled. The most notable findings concern the regions of trauma. Among 1,273 patients who underwent X-rays of the hand region, 617 (48%) showed fractures, and 656 (51%) did not. Of the 744 X-rays performed for the foot region, 235 (31%) revealed fractures, while 509 (68%) were negative for fractures. In the upper limbs region, 1,334 X-rays were performed, with 1,079 (80%) identifying fractures and 255 (20%) showing no fractures. For the lower limbs region, 479 X-rays were conducted, 204 (42%) of which revealed fractures, while 275 (58%) were negative for fractures. All these results demonstrated statistically significant differences (P < 0.05). Conclusions: Despite the limitations of the study's retrospective design and its single-center setting, the findings highlight a high prevalence of X-rays in the hand and upper limb regions, often with positive results. In contrast, radiography of the lower limbs and feet frequently yielded negative findings, suggesting potential overuse. Future research should investigate the clinical utility of musculoskeletal ultrasound as an alternative imaging modality to minimize unnecessary radiation exposure in pediatric patients.
Virtual reality in pediatric emergency department and burn unit: a scoping review of current applications Ignazio Cammisa, Gemma Eftimiadi, David Korn, Serena Ferretti, Lavinia Capossela, Antonio Gatto, Antonio Chiaretti Emergency Care Journal, 2025 Virtual reality (VR) represents an innovative and effective tool for reducing pain and anxiety in children undergoing painful procedures in pediatric emergency departments and burn units. VR has the ability to modulate both the sensory and emotional components of pain by immersing children in a virtual world, effectively diverting their attention from the painful experience. Specifically, VR distraction competes for the patient’s attentional resources, reducing their focus on the painful stimulus and, consequently, diminishing the perception of pain. The primary objective of this review was to assess and summarize the current knowledge regarding the use of VR for painful procedures in pediatric emergency and burn units by comparing and analyzing the existing literature. Of the 340 articles reviewed, 25 met the selection criteria and were included in the analysis. These studies examined the use of VR in venous procedures (such as venipuncture, cannulation, and blood sampling) as well as other procedures, including laceration repair and burn wound care. The findings indicated that 20 studies reported a reduction in pain scores, while 9 studies noted a reduction in anxiety scores. Additionally, three studies demonstrated a reduction in procedural time. Overall, the studies supported the efficacy, safety, and feasibility of VR in managing procedural pain and anxiety in pediatric settings. Furthermore, VR use contributed to a reduction in parental and medical stress levels, as well as a decrease in the time spent in the pediatric emergency room. Studies involving larger sample sizes may provide further evidence of VR’s effectiveness across different procedures and age groups.
Intranasal Human-Recombinant Nerve Growth Factor Enhances Motor and Cognitive Function Recovery in a Child with Severe Traumatic Brain Injury Lorenzo Di Sarno, Lavinia Capossela, Serena Ferretti, Luigi Manni, Marzia Soligo, Susanna Staccioli, Eleonora Napoli, Riccardo Burattini, Antonio Gatto, Antonio Chiaretti Pharmaceuticals, 2025 Introduction: Traumatic brain injury (TBI) in pediatric population is responsible for significant mortality and morbidity, particularly among children aged 0–4 and young adults aged 15–24. The developing brain’s unique characteristics may increase vulnerability to injuries, potentially leading to long-term cognitive and motor deficits. Current therapeutic options for neuronal regeneration post-TBI are limited, although neurotrophins, especially nerve growth factor (NGF), show promise in enhancing recovery. NGF can mitigate excitotoxicity and promote neuroprotection, particularly by intranasal administration, which is attractive because of its non-invasive nature. Case Presentation: A three-year-old boy suffered from severe TBI due to a car accident, leading to multiple complications, including a basilar skull fracture and cerebral venous sinus thrombosis. Initial assessments revealed significant neurological impairments. After intensive care and rehabilitation, the child exhibited gradual improvements in consciousness and motor functions but continued to face challenges, particularly with left-sided hemiparesis. Nine months post-injury, he began intranasal administration of human-recombinant NGF (hr-NGF) as part of a clinical trial. Discussion: Following hr-NGF treatment, the child demonstrated notable advancements in motor function, achieving independent standing and walking. Cognitive assessments indicated improvements in various domains, including verbal comprehension and executive functioning. EEG results showed reduced epileptiform activity. These findings suggest that hr-NGF may facilitate recovery in pediatric TBI cases by enhancing both motor and cognitive outcomes. Conclusions: This case highlights the potential role of intranasal hr-NGF administration as a therapeutic strategy for improving neurological recovery in children with severe TBI. The positive clinical outcomes support further exploration of NGF as a viable treatment option to mitigate long-term sequelae associated with pediatric brain injuries.
Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome Antonio Gatto, Lavinia Capossela, Giorgio Conti, Gemma Eftimiadi, Serena Ferretti, Luigi Manni, Antonietta Curatola, Benedetta Graglia, Lorenzo Di Sarno, Maria Lucia Calcagni, Daniela Di Giuda, Stefano Cecere, Domenico Marco Romeo, Marzia Soligo, Enzo Picconi, Marco Piastra, Giacomo Della Marca, Susanna Staccioli, Antonio Ruggiero, Fabrizio Cocciolillo, Silvia Pulitanò, Antonio Chiaretti Biology Direct, 2023
SARS-CoV-2-related bronchiolitis: A multicentre international study Giorgio Cozzi, Aleksandar Sovtic, Davide Garelli, Uros Krivec, Davide Silvagni, Ilaria Corsini, Marco Colombo, Manuela Giangreco, Antonietta Giannattasio, Gregorio Paolo Milani, Marta Minute, Federico Marchetti, Antonio Gatto, Carla Debbia, Anna Jolanda Gortan, Marta Massaro, Elpis Hatziagorou, Domenico Ravidà, Raz Diamand, Elizabeth Jones, Jelena Visekruna, Alessandro Zago, Egidio Barbi, Alessandro Amaddeo, Luisa Cortellazzo Wiel Archives of Disease in Childhood, 2023
Pain management in pediatric age. An update L. Di Sarno, A. Gatto, D. Korn, V. Pansini, A. Curatola, S. Ferretti, L. Capossela, B. Graglia, A. Chiaretti Acta Biomedica, 2023
Prevalence of SARS-CoV-2 positivity in infants with bronchiolitis: A multicentre international study Giorgio Cozzi, Luisa Cortellazzo Wiel, Alessandro Amaddeo, Antonio Gatto, Manuela Giangreco, Adi Klein-Kremer, Samantha Bosis, Davide Silvagni, Carla Debbia, Laura Nanni, Sara Chiappa, Marta Minute, Ilaria Corsini, Giuliana Morabito, Anna Jolanda Gortan, Marco Colombo, Federico Marchetti, Davide Garelli, Arianna Piffer, Fabio Cardinale, Nitai Levy, Antonietta Curatola, Bojana Gojsina, Suvradeep Basu, Egidio Barbi, Aleksandar Sovtic Archives of Disease in Childhood, 2022
Correction: Diagnosis and management of urinary tract infections in children aged 2 months to 3 years in the Italian emergency units: the ItaUTI study (European Journal of Pediatrics, (2022), 181, 7, (2663-2671), 10.1007/s00431-022-04457-0) Francesca Cenzato, Gregorio P. Milani, Angela Amigoni, Francesca Sperotto, Mario G. Bianchetti, Carlo Agostoni, Giovanni Montini, Giovanni Farello, Francesco Chiarelli, Rita Greco, Franco Di Lollo, Fabio Rocco Forte, Sergio Manieri, Luigi Carpino, Mimma Caloiero, Anastasia Cirisano, Salvatore Braghò, Roberto Della Casa, Felice Nunziata, Carmine Pecoraro, Rosario Pacifico, Marcello Lanari, Chiara Ghizzi, Laura Serra, Marcello Stella, Giuseppe Maggiore, Roberto Fiorini, Icilio Dodi, Andrea Morelli, Lorenzo Lughetti, Andrea Cella, Gianluca Vergine, Alessandro De Fanti, Danica Dragovic, Daniele Santori, Giorgio Cozzi, Paola Cogo, Marilena Raponi, Riccardo Lubrano, Mauro de Martinis, Antonio Gatto, Maria Antonietta Barbieri, Antonino Reale, Giorgio Bracaglia, Emanuela Piccotti, Riccardo Borea, Alberto Gaiero, Laura Martelli, Alberto Arrighini, Paola Cianci, Claudio Cavalli, Leonardina De Santis, Benedetta Chiara Pietra, Andrea Biondi, Marco Sala, Laura M. Pogliani, Simonetta Cherubini, Marta Bellini, Paola Bruni, Giovanni Traina, Paola Tommasi, Paolo Del Barba, Sergio Arrigoni, Filippo M. Salvini, Luca Bernardo, Giuseppe Bertolozzi, Silvia Fasoli, Gian Luigi Marseglia, Emilio Palumbo, Annalisa Bosco, Gianpaolo Mirri, Elisabetta Fabiani, Ermanno Ruffini, Luisa Pieragostini, Martina Fornaro, Gabriele Ripanti, Donnina Pannoni, Felici Enrico, Anna Perona, Eleonora Tappi, Oscar Nis Haitink, Ivana Rabbone, Pina Teresa Capalbo, Antonio Urbino, Andrea Guala, Gianluca Cosi, Maria Gabriella Barracchia, Baldassarre Martire, Fabio Cardinale, Fulvio Moramarco, Carmelo Perrone, Angelo Campanozzi, Valerio Cecinati, Alessandro Canetto, Ciro Clemente, Antonio Cualbu, Fabio Narducci, Giuseppina Mula, Pasquale Bulciolu, Roberto Antonucci, Giuseppe Gramaglia, Giuseppe Cavaleri, Carmelo Salpietro, Giovanni Corsello, Rosario Salvo, Marcello Palmeri, Maria Assunta Vitale, Ambra Morgano, Susanna Falorni, Diego Peroni, Stefano Masi, Alessio Bertini, Angelina Vaccaro, Pierluigi Vasarri, Petra Reinstadler, Massimo Soffiati, Maurizio Stefanelli, Alberto Verrotti di Pianella, Catherine Bertone, Stefano Marzini, Liviana Da Dalt, Simone Rugolotto, Floriana Scozzola, Luca Ecclesio Livio, Mauro Cinquetti, Davide Silvagni, Massimo Bellettato, and European Journal of Pediatrics, 2022
Diagnosis and management of urinary tract infections in children aged 2 months to 3 years in the Italian emergency units: the ItaUTI study Francesca Cenzato, Gregorio P. Milani, Angela Amigoni, Francesca Sperotto, Mario G. Bianchetti, Carlo Agostoni, Giovanni Montini, Giovanni Farello, Francesco Chiarelli, Rita Greco, Franco Di Lollo, Fabio Rocco Forte, Sergio Manieri, Luigi Carpino, Mimma Caloiero, Anastasia Cirisano, Salvatore Braghò, Roberto Della Casa, Felice Nunziata, Carmine Pecoraro, Rosario Pacifico, Marcello Lanari, Chiara Ghizzi, Laura Serra, Marcello Stella, Giuseppe Maggiore, Roberto Fiorini, Icilio Dodi, Andrea Morelli, Lorenzo Lughetti, Andrea Cella, Gianluca Vergine, Alessandro De Fanti, Danica Dragovic, Daniele Santori, Giorgio Cozzi, Paola Cogo, Marilena Raponi, Riccardo Lubrano, Mauro de Martinis, Antonio Gatto, Maria Antonietta Barbieri, Antonino Reale, Giorgio Bracaglia, Emanuela Piccotti, Riccardo Borea, Alberto Gaiero, Laura Martelli, Alberto Arrighini, Paola Cianci, Claudio Cavalli, Leonardina De Santis, Benedetta Chiara Pietra, Andrea Biondi, Marco Sala, Laura M. Pogliani, Simonetta Cherubini, Marta Bellini, Paola Bruni, Giovanni Traina, Paola Tommasi, Paolo Del Barba, Sergio Arrigoni, Filippo M. Salvini, Luca Bernardo, Giuseppe Bertolozzi, Silvia Fasoli, Gian Luigi Marseglia, Emilio Palumbo, Annalisa Bosco, Gianpaolo Mirri, Elisabetta Fabiani, Ermanno Ruffini, Luisa Pieragostini, Martina Fornaro, Gabriele Ripanti, Donnina Pannoni, Felici Enrico, Anna Perona, Eleonora Tappi, Oscar Nis Haitink, Ivana Rabbone, Pina Teresa Capalbo, Antonio Urbino, Andrea Guala, Gianluca Cosi, Maria Gabriella Barracchia, Baldassarre Martire, Fabio Cardinale, Fulvio Moramarco, Carmelo Perrone, Angelo Campanozzi, Valerio Cecinati, Alessandro Canetto, Ciro Clemente, Antonio Cualbu, Fabio Narducci, Giuseppina Mula, Pasquale Bulciolu, Roberto Antonucci, Giuseppe Gramaglia, Giuseppe Cavaleri, Carmelo Salpietro, Giovanni Corsello, Rosario Salvo, Marcello Palmeri, Maria Assunta Vitale, Ambra Morgano, Susanna Falorni, Diego Peroni, Stefano Masi, Alessio Bertini, Angelina Vaccaro, Pierluigi Vasarri, Petra Reinstadler, Massimo Soffiati, Maurizio Stefanelli, Alberto Verrotti di Pianella, Catherine Bertone, Stefano Marzini, Liviana Da Dalt, Simone Rugolotto, Floriana Scozzola, Luca Ecclesio Livio, Mauro Cinquetti, Davide Silvagni, Massimo Bellettato, and European Journal of Pediatrics, 2022
Cytokine response to sars-cov-2 infection in children Antonietta Curatola, Antonio Chiaretti, Serena Ferretti, Giulia Bersani, Donatella Lucchetti, Lavinia Capossela, Alessandro Sgambato, Antonio Gatto Viruses, 2021
Children's Healthcare During Corona Virus Disease 19 Pandemic: the Italian Experience Danilo Buonsenso, Roberta Onesimo, Piero Valentini, Antonio Chiaretti, Antonio Gatto, Giorgio Attinà, Giorgio Conti, Giovanni Vento, Andrea Cambieri, Eugenio Mercuri, Giuseppe Zampino, on behalf of the pedCOVID-team Pediatric Infectious Disease Journal, 2020
Lung ultrasound in infants with bronchiolitis Danilo Buonsenso, Anna Maria Musolino, Antonio Gatto, Ilaria Lazzareschi, Antonietta Curatola, Piero Valentini BMC Pulmonary Medicine, 2019
Second-generation immigrant children: Health prevention for a new population in terms of vaccination coverage and health assessment Minerva Pediatrica, 2016
Focus on desmopressin and enuresis: A review of literature Minerva Urologica E Nefrologica, 2016
Immunization status of children in foster homes: The first Italian data Minerva Pediatrica, 2016
Nephrotic syndrome following H1N1 influenza in a 3-year-old boy Iranian Journal of Pediatrics, 2012
Cardamom ingestion as a possible cause of hematuria Pietro Ferrara, Iliana Bersani, Giorgia Bottaro, Ottavio Vitelli, Antonio Gatto, Francesca del Bufalo, Pio Liberatore, Lorenza Romani, Achille Stabile Indian Journal of Pediatrics, 2011